Table 4 Studies of lymphangiogenesis and prognosis in primary malignant melanoma

From: Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis

Series

Cases

Antibodies

Computer-assisted morphometric analysis

Main findings

Dadras36

37

LYVE-1, CD31, VEGF-C

Yes

Increased intratumoral LV associated with metastatic melanoma and correlates with poor DFS. High-relative LV area was associated with poor DFS and OS.

Straume37

220

LYVE-1, Podoplanin, Ki-67

No

Decreased LV density was present in thicker and more proliferative melanomas. Increased LV density was significantly associated with improved patient survival in multivariate analysis.

Giorgadze38

29

D2-40, CD31

No

Intratumoral LV density higher in invasive melanomas compared to acquired or dysplastic nevi.

Shields39

21

LYVE-1, CD31, VEGFR-3, VEGF-C, VEGF-D

No

Increased LV density associated with metastases. No comment on survival.

Valencak40

120

Podoplanin, CD31

No

Increased LV density was significantly associated with poor OS and poor DFS (univariate). Increased CD31 was significantly associated with poor DFS and OS in multivariate analysis.

Dadras31

45

CD31, LYVE-1, D2-40, VEGF-C, VEGF-D

Yes

Increased LV density and area in SLN+ cases. LV area was the most sensitive prognostic marker for SLN metastasis. Higher VEGF-C expression in SLN+ melanomas.

Sahni41

36

LYVE-1

No

No significant difference in LV density between SLN+ and SLN− cases. Higher peritumoral LV density in ulcerated melanomas.

Massi42

45

D2-40, VEGF-C

Yes

Number and area of LV was significantly higher in melanomas associated with SLN metastasis. By logistic regression analysis, intratumoral LV area resulted the most significant predictor of SLN metastasis (P=0.04). By multivariate analysis, peritumoral LV density resulted an independent variable affecting OS.

  1. DFS, disease-free survival; LV, lymphatic vessels; OS, overall survival.